Connection

Cristina Gervasoni to HIV Integrase Inhibitors

Back to Details
This is a "connection" page, showing publications Cristina Gervasoni has written about HIV Integrase Inhibitors.
Cristina Gervasoni
Connection Strength
2.576
HIV Integrase Inhibitors
  1. Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor. Eur J Drug Metab Pharmacokinet. 2019 Jun; 44(3):319-327.
    View in: PubMed
    Score: 0.679
  2. Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference. J Antimicrob Chemother. 2017 06 01; 72(6):1842-1844.
    View in: PubMed
    Score: 0.591
  3. How Relevant is the Interaction Between Dolutegravir and Metformin in Real Life? J Acquir Immune Defic Syndr. 2017 05 01; 75(1):e24-e26.
    View in: PubMed
    Score: 0.587
  4. Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect? Antivir Ther. 2017; 22(4):353-356.
    View in: PubMed
    Score: 0.573
  5. Intolerance of dolutegravir-containing combination antiretroviral therapy: not just a pharmacokinetic drug interaction. AIDS. 2017 03 27; 31(6):867-868.
    View in: PubMed
    Score: 0.146
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.